Nykredit A/S’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$199M Buy
6,985,219
+602,492
+9% +$16M 0.73% 21
2026
Q2
$154M Buy
+6,382,727
New +$167M 0.59% 36

Other funds holding PFE

Nykredit A/S's PFE Position: Q3 2026 in Review

Nykredit A/S increased its Pfizer (PFE) stake by 9.4% in Q3 2026, buying an estimated $16M and bringing the position to 6,985,219 shares worth $199M. The position accounts for 0.73% of the portfolio, ranked #21.

Nykredit A/S first reported a position in PFE in Q2 2026 and has held it in 2 quarters since. 2,601 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Nykredit A/S held 6,985,219 shares of Pfizer worth $199M as of Q3 2026.
  • Nykredit A/S bought 602,492 Pfizer shares in Q3 2026, an estimated $16M.
  • Pfizer made up 0.73% of Nykredit A/S's portfolio in Q3 2026, its #21 holding.
  • Nykredit A/S first reported a position in Pfizer in Q2 2026 and has held it in 2 quarters since.
  • 2,601 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Nykredit A/S's 13F filing for Q3 2026, filed 6 Nov 2026.